Pollsters were surprised by the burst of populism in 2016, but many now think they shouldn’t have been. In the United States and United Kingdom, swaths of voters in deprived regions – places “left behind” by globalization – were given the chance to stick it to the system, and they…
Berkshire Hathaway needs no introduction. The name is synonymous with two iconic investors—Warren Buffett (the Oracle of Omaha) and the late Charlie Munger. Currently, Berkshire’s Class B shares (BRK/B) appear to be hovering at a tense standstill, poised for a major breakout either upward or downward. The shares are midpoint…
On this week’s edition of Stock Talk with Joe Rabil, Joe goes through the history of stock market bubbles, sharing what they look like, how they typically end, and how it relates to NVDA, MSFT, AAPL and GOOGL. Joe also covers the stock requests that came through this week, including…
Boss Energy Limited (ASX: BOE; OTCQX: BQSSF) is pleased to announce high-grade drill results on theGould’s Dam satellite deposit. Highlights Gould’s Dam is located ~80km northwest of the Honeymoon Mine and currently contains a JORC-compliant resource of 25Mlbs of indicated and inferred U308 The results highlight the potential for Gould’s…
Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to announce progress in its regulatory strategy for its first commercial product, the pre-surgical triage test. Highlights Initial pre-submission meeting held with the U.S. Food & Drug Administration (FDA) where CLEO outlined its submission framework and…
Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSX- V:SWA) is pleased to report that on 25 June 2024, it closed tranche 1 of its previously announced A$1m equity placement (the “Placement”) (refer to Sarama’s news release dated 19 June 2024). Tranche 1 of the Placement raised aggregate gross proceeds…
The wide-ranging oncology market covers every area of cancer care, from diagnosis to treatment. Coming in only after cardiovascular disease, cancer is the second leading cause of death worldwide; unsurprisingly, oncology is one of the biggest sectors in the life science space. With that in mind, biotechnology and pharmaceutical companies…
Regardless of how the gold price is doing, the top gold-mining companies are always making moves. Right now, the yellow metal is in the limelight — stimulated by increasing global inflation, geopolitical turmoil and recession fears, the price of gold set records in 2024, breaking through the US$2,400 per ounce…
Overview Cardiol Therapeutics. (NASDAQ:CRDL,TSX:CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company’s lead small molecule drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the…
(TheNewswire) Company now gearing up and actively enhancing its supply chain of fully integrated electrolyzers with capacities up to 2.5 MW, 5.0 MW and 10.0 MW for all of its projects Brossard, Quebec, June 25 2024 TheNewswire Charbone Hydrogen Corporation (TSXV: CH; OTCQB: CHHYF; FSE: K47) (the ‘ Company ‘…